CD28 and COVID-19: Next, patients with acute COVID-19 had elevated numbers of peripheral blood CD4+ T cells simultaneously producing IL-2 and IL-17 than healthy controls in response to in vitro stimulation with anti-CD3/CD28, pointing to effector Th skewing toward the Th17 phenotype [43].